O

Orakl Oncology

AI-driven tumor modeling for personalized oncology

AI & Biology Research Scientist

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeVillejuif, FranceNo salary listedHybrid

About the Job

Requirements

  • A PhD and postdoctoral experience in computational biology, including machine learning or machine learning applied to genomics, with a track record of independent research such as publications or methods driven end to end.
  • Strong experience in transcriptomic and multi-omics analysis, including RNA-seq and ideally WGS/WES or other omics.
  • Proficiency in Python and its data and bioinformatics ecosystem, such as scanpy, PyDESeq2, scikit-learn, and pandas.
  • Comfort with classical machine learning.
  • Fluency in English.
  • Ability to conduct applied research autonomously, with no immediate managerial ambition.
  • Ability to scope a minimum viable product, accept an imperfect first pass, and iterate quickly.
  • Care for data integrity and reproducibility.

Responsibilities

  • Develop computational methods to analyze and interpret multi-omic data, including methods for target identification, validation, and stratification to initiate nomination.
  • Connect analysis methods with platform and engineering teams to develop the product portfolio, and collaborate with research engineers to create production-grade deliverables for internal and external stakeholders.
  • Collaborate cross-functionally to build data packages that support program milestones and internal investment decisions.
  • Contribute to the team's scientific culture through rigor, reproducibility, data integrity, and biological relevance.

Desired Qualifications

  • Exposure to causal inference or network methods.
  • Knowledge of cancer biology, including KRAS biology, DDR/HRR, or Wnt pathways.
  • Experience with functional drug-response data, such as pharmacogenomics or screening.
  • Familiarity with preclinical models such as organoids or PDOs.
  • Solid software practices, including Git and reproducible environments, to support handoffs to engineering.

About the Company

Orakl Oncology

AI-driven tumor modeling for personalized oncology

Orakl Oncology uses artificial intelligence to analyze experimental and patient data to build tumor models that mirror real drug responses, enabling personalized medicine in oncology. Its AI-powered data analysis identifies cancer biology patterns and translates them into tumor models, which collaborators in the oncology field can use to test and tailor treatments. The product works by integrating diverse data sources and applying AI to simulate how tumors react to different drugs, producing insights and predictive models for decision-making. Compared to competitors, Orakl Oncology focuses on combining AI with both experimental and patient data to create highly representative tumor models and to support B2B partnerships with other oncology companies, not consumer-facing applications. The company aims to help clients develop more effective, personalized cancer therapies by providing data-driven models and analyses that accelerate drug development and precision treatment strategies.

Company size
11-50
Company stage
Series A
Total funding
$49.4M
Headquarters
Paris, France
Founded
2023

Recently Posted Jobs

Explore more opportunities at Orakl Oncology

See more jobs